107 Spam-Free Article(s) Found
||Halozyme Therapeutics, Inc.
Nov 29, 2019 - Halo Labs (OTCQX:AGEEF) will hold a conference call today at 4:00 pm ET to discuss the signing of the Bophelo acquisition and general update on the California strategy due to the large volume of requ
Nov 15, 2019 -
Halo Labs Inc. (OTC: AGEEF) posted third-quarter revenue of $7.2 million Thursday, up 99% year-over-year.
The company’s gross profit and gross margin for the quarter were $2.9 million and 41%, respectively.
The cost of goods sold amounted to $4.2 million in the quarter.
Nov 15, 2019 -
Nov 12, 2019 - HALO earnings call for the period ending September 30, 2019.
Nov 12, 2019 - Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q3 2019 Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Albert Kildani - Vice President of Investor Relations and Corporate Communi
Nov 05, 2019 - Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nov 05, 2019 - Barclays issues rating change for HALO
Oct 17, 2019 -
Better Choice Company (OTC: BTTR), an animal health and wellness CBD company, said Wednesday it signed a definitive agreement to acquire holistic pet foods company Halo, Purely for Pets.
Oct 07, 2019 -
Halo Labs Inc. (OTC: AGEEF) said Monday it has signed an agreement to purchase all common shares of Cannpos Services Corp.
Sep 13, 2019 - Roche's (RHHBY) new fixed-dose combination of Perjeta and Herceptin meets the primary endpoint in the phase III study for treating patients with HER2-positive early breast cancer.